| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VERV | Common Stock | Gift | $0 | -160K | -33.48% | $0.00 | 318K | Jul 7, 2022 | Direct | F1, F2 |
| transaction | VERV | Common Stock | Gift | $0 | +160K | +197.54% | $0.00 | 241K | Jul 7, 2022 | Kathiresan Family 2021 Irrevocable Trust | F1 |
| holding | VERV | Common Stock | 81K | Jul 7, 2022 | Sekar Kathiresan 2021 Irrevocable Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VERV | Stock Option (right to buy) | Gift | $0 | -140K | -32.41% | $0.00 | 292K | Jul 12, 2022 | Common Stock | 140K | $8.24 | Direct | F3, F4 |
| transaction | VERV | Stock Option (right to buy) | Gift | $0 | -160K | -26.43% | $0.00 | 445K | Jul 12, 2022 | Common Stock | 160K | $2.87 | Direct | F5, F6 |
| transaction | VERV | Stock Option (right to buy) | Gift | $0 | +140K | $0.00 | 140K | Jul 12, 2022 | Common Stock | 140K | $8.24 | Sekar Kathiresan 2022 Annuity Trust | F3, F7 | |
| transaction | VERV | Stock Option (right to buy) | Gift | $0 | +160K | +114.29% | $0.00 | 300K | Jul 12, 2022 | Common Stock | 160K | $2.87 | Sekar Kathiresan 2022 Annuity Trust | F5, F7 |
| Id | Content |
|---|---|
| F1 | On July 7, 2022, the reporting person transferred 160,000 shares of Verve Therapeutics, Inc. (the "Company") common stock to a family trust. Members of the reporting person's immediate family are the beneficiaries of the trust. |
| F2 | Includes 314 shares of the Company's common stock acquired under the Verve Therapeutics, Inc. Amended and Restated 2021 Employee Stock Purchase Plan. |
| F3 | On July 12, 2022, the reporting person transferred an employee stock option to purchase 140,000 shares of common stock of the Company to a grantor retained annuity trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust. |
| F4 | The remaining shares underlying this option, which was granted on February 12, 2021, vest in equal monthly installments until February 1, 2025. |
| F5 | On July 12, 2022, the reporting person transferred an employee stock option to purchase 160,000 shares of common stock of the Company to a grantor retained annuity trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust. |
| F6 | The remaining shares underlying this option, which was granted on September 16, 2020, vest in equal monthly installments until September 16, 2024. |
| F7 | The shares underlying the option being transferred were fully vested as of the date of transfer. |